Rare diseases
Investigational molecules
Locations
Back to Italy116 clinical trials in Chieti, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
ItalyStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
ItalyStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
ItalyStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
ItalyStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
ItalyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
ItalyFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
ItalyPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
ItalyA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
ItalyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis treatments and management of Parkinson's disease. Clinical trials are evaluating new therapeutic approaches including frexalimab for relapsing MS and novel subcutaneous infusion therapies for advanced Parkinson's.
Comprehensive studies examining treatments for type 2 diabetes and cardiovascular conditions. Research includes evaluation of tirzepatide and innovative approaches for stroke prevention in patients with atrial fibrillation.
Advanced research in chronic kidney disease and end-stage renal disease, investigating novel dialysis solutions and treatment combinations. Studies focus on improving outcomes for patients requiring peritoneal dialysis.
Clinical investigations of treatments for atopic dermatitis and other skin conditions. Studies evaluate new biological therapies and targeted treatments for various dermatological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
